drugset / Trial / NCT04016220

Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma

NCT04016220

Phase 1 Unknown 60 enrolled University of Monastir
RandomizedParallel-groupDouble-blindTreatment

Summary

Our study is a prospective double-blind randomized study performed in the Emergency Department (ED). The objective of our study was to demonstrate the additive effect of high and repeated doses of inhaled budesonide combined with the standard treatment of acute asthma in adult managed in the ED

Timeline

Start
2019-05-20
Primary completion
2019-12-20
Completion
2020-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 0.5 mg Inhaled

Indications